Compare CNXN & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNXN | ENOV |
|---|---|---|
| Founded | 1982 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Fluid Controls |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 1997 | 2008 |
| Metric | CNXN | ENOV |
|---|---|---|
| Price | $64.24 | $25.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $47.38 |
| AVG Volume (30 Days) | 51.6K | ★ 670.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.24 | $6.36 |
| Revenue Next Year | $4.39 | $5.31 |
| P/E Ratio | $19.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.97 | $21.00 |
| 52 Week High | $71.17 | $36.82 |
| Indicator | CNXN | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 61.35 |
| Support Level | $61.71 | $21.37 |
| Resistance Level | $65.39 | $26.41 |
| Average True Range (ATR) | 1.64 | 1.04 |
| MACD | 0.72 | 0.31 |
| Stochastic Oscillator | 93.14 | 87.56 |
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.